Clinical trial
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities
NCT05311709
Study timeline
Study start (actual)2022-05-30Date precision: day
Registry last updated2023-11-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
NSCLC, Stage IIIunresolved
NSCLC Stage IVunresolved
Lung Cancer Stage IVunresolved
Mutationunresolved
Cancerunresolved
Cancer, Lungunresolved
Interventions
sotorasibDRUG · verified · RxNorm: sotorasib
Sponsors & collaborators
Vestre Viken Hospital Trustlead sponsor
Aarhus University Hospitalcollaborator
Oslo University Hospitalcollaborator
Copenhagen University Hospital, Rigshospitaletcollaborator
Odense University Hospitalcollaborator
Karolinska University Hospitalcollaborator
University Hospital of North Norwaycollaborator
Haukeland University Hospitalcollaborator
St. Olavs Hospitalcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05311709 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.